Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication

Xiaoning Si, Yahong Wang, Jerry Wong, Jingchun Zhang, Bruce M. McManus, Honglin Luo
Xiaoning Si
1Department of Pathology and Laboratory Medicine, The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia-St. Paul's Hospital, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yahong Wang
1Department of Pathology and Laboratory Medicine, The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia-St. Paul's Hospital, Vancouver, British Columbia, Canada
2Chinese Internal Medicine Laboratory, Department of Cardiology, Dongzhimen Hospital Affiliated with Beijing University of Chinese Medicine, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Wong
1Department of Pathology and Laboratory Medicine, The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia-St. Paul's Hospital, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingchun Zhang
1Department of Pathology and Laboratory Medicine, The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia-St. Paul's Hospital, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce M. McManus
1Department of Pathology and Laboratory Medicine, The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia-St. Paul's Hospital, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Honglin Luo
1Department of Pathology and Laboratory Medicine, The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia-St. Paul's Hospital, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hluo@mrl.ubc.ca
DOI: 10.1128/JVI.02028-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Curcumin decreases replication of CVB3. (A) HeLa cells were sham infected with PBS or infected with CVB3 in the absence or presence of curcumin (30 μM). Six hours postinfection, viral RNA was detected by in situ hybridization using antisense riboprobes for CVB3 (red). Cell nuclei were counterstained with hematoxylin (blue). The data represent the results from two independent experiments. (B) HeLa cells were infected and treated with various concentrations of curcumin as for panel A. Seven hours postinfection, CVB3 viral-protein synthesis was examined using a monoclonal antibody that recognizes the CVB3 capsid protein VP1. To verify equal loading, the same blots were stripped and reprobed for β-actin. The data represent results from three independent experiments. (C) HeLa cells were infected and treated with curcumin as for panel A. Nine hours postinfection (p.i.), medium was collected and CVB3 progeny were measured by plaque assay. The data are means plus standard deviations (SD); n = 3; #, P < 0.005 compared to DMSO treatment. (D) HeLa cells were infected with 35S-labeled CVB3 for 1 h. Cell lysates were collected and measured for radioactivity using a scintillation counter (mean ± SD; n = 6). CPM, counts per minute. (E) HeLa cells were infected with CVB3, and curcumin (30 μM) was added to the cells at different times as indicated. Seven hours postinfection, cell lysates were collected and expression levels of VP1 and β-actin were examined.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Curcumin reduces CVB3-induced cytopathic effect and apoptosis. HeLa cells were sham infected with PBS or infected with CVB3 in the absence or presence of curcumin (30 μM). (A) Seven hours postinfection, the morphologies of infected cells were examined under a phase-contrast microscope. Representative images from three independent experiments are presented. (B) Cell lysates were prepared 7 h postinfection (p.i.), and cleavage of caspase 3 was examined using a monoclonal anti-capase 3 antibody. β-Actin was examined to show equal protein loading. The data represent the results from two independent experiments.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Curcumin does not inhibit replication of CVB3 through MAPK pathways. HeLa cells were infected with CVB3 in the absence or presence of curcumin (10 and 30 μM). Seven hours postinfection (p.i.), the phosphorylation status of MAPKs was examined using anti-phospho-ERK1/2, anti-phospho-p38, and anti-phospho-JNK1/2 antibodies, respectively. Expression levels of total ERK1/2, p38, and JNK1/2 were examined as the loading controls. The data represent the results from two independent experiments.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Curcumin probably does not inhibit replication of CVB3 through CKII and CSN. HeLa cells were transiently transfected with specific siRNAs to knock down the expression of CKIIα (A), CKIIα/β (B), or Jab1 (C), respectively, for 24 h. Seven hours after CVB3 infection, viral protein expression (VP1) and levels of CKIIα, CKIIβ, and Jab1 were determined by Western blotting. β-Actin was examined to verify equal loading. The data represent the results from three independent experiments.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Curcumin promotes protein polyubiquitination and decreases free ubiquitin levels. (A) HeLa cells were treated with DMSO or curcumin (30 μM) for 5 h. Protein polyubiquitination and free ubiquitin levels were examined by Western blot analysis using a polyclonal anti-ubiquitin antibody. β-Actin was examined to verify equal loading. (B) HeLa cells were incubated with either DMSO, MG132 (5 μM), or curcumin (30 μM) for 5 h. Ubiquitin conjugates were determined as for panel A. Multiple lanes represent the results from independent experiments.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Curcumin inhibits 20S proteasome activities. (A) HeLa cells were treated with DMSO, curcumin (30 μM), or MG132 (5 μM) for 5 h. The activities of 20S proteasome, including trypsin-like, chymotrypsin-like, and PDGH activities, in the cell lysates were measured as described in Materials and Methods. (B) Purified 20S proteasome (100 ng) was used to examine the effects of curcumin (30 μM) and MG132 (5 μM) on proteasome hydrolytic activities. The data are means plus standard deviations; n = 3. *, P < 0.01; #, P < 0.005; δ, P < 0.001 compared to DMSO treatment.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Curcumin reduces cellular deubiquitinating activities. (A) HeLa cells were sham infected with PBS or infected with CVB3 for 6 h. Cell lysates were prepared, and cellular deubiquitinating activities were measured using a fluorogenic substrate, ubiquitin-AMC, as described in Materials and Methods. (B) HeLa cells were treated with DMSO, curcumin (30 μM), or MG132 (5 μM) for 5 h, and cellular deubiquitinating activities were measured. The data are means plus standard deviations; n = 3. #, P < 0.005 compared to DMSO treatment.

PreviousNext
Back to top
Download PDF
Citation Tools
Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication
Xiaoning Si, Yahong Wang, Jerry Wong, Jingchun Zhang, Bruce M. McManus, Honglin Luo
Journal of Virology Mar 2007, 81 (7) 3142-3150; DOI: 10.1128/JVI.02028-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication
Xiaoning Si, Yahong Wang, Jerry Wong, Jingchun Zhang, Bruce M. McManus, Honglin Luo
Journal of Virology Mar 2007, 81 (7) 3142-3150; DOI: 10.1128/JVI.02028-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Curcumin
Enterovirus B, Human
Proteasome Endopeptidase Complex
ubiquitin
virus replication

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514